Kidswell Bio CorporationJP:4584Income statement

Market cap
¥12.3B
P/E ratio
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Revenue207613013221,1611,0891,0601,0221,0789971,5692,7762,4315,082
Revenue growth (%)-
Cost of revenue---1485013974224126531205501,2511,3923,442
Gross profit---1746606926376094258771,0191,5261,0391,640
Gross margin (%)---
Operating margin (%)---
Operating expenses ---9981,4801,8771,5511,4151,5861,8471,9382,0772,3751,612
Operating income ----824-820-1,184-913-806-1,161-970-919-551-1,33628
Income before tax -318-374-517-790-786-1,177-903-816-1,187-991-953-625-1,3905
Pretax margin (%)-153.3-617.3-171.5-245.7-67.7-108-85.2-79.9-110.2-99.5-60.7-22.5-57.20.1
Provision for income taxes---222222221294
Effective tax rate (%)---
Net income -321-377-519-792-788-1,225-905-856-7,316-1,001-535-657-1,422-21
Earnings per share-268.1-238.2-240.15-331.86-302.91-137.01-94.54-43.84-264.65-34.79-17.35-20.77-40.23-0.52
Diluted EPS-------------12.5
Dividend payout ratio (%)--------------
Dividend per share--------------